Health Care & Life Sciences » Pharmaceuticals | Sinil Pharmaceutical Co. Ltd.

Sinil Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
7,324
10,179
8,764
10,038
7,591
Depreciation, Depletion & Amortization
2,078
2,088
2,463
3,019
3,418
Other Funds
139
408
522
19
150
Funds from Operations
13,062
13,952
11,975
14,209
13,237
Changes in Working Capital
804
4,623
2,411
9,974
4,286
Net Operating Cash Flow
12,259
9,329
9,564
4,235
8,951
Capital Expenditures
5,382
3,047
5,802
2,568
3,924
Sale of Fixed Assets & Businesses
23
383
28
12
64
Purchase/Sale of Investments
5,907
5,485
4,594
1,796
2,712
Net Investing Cash Flow
11,448
8,120
10,217
4,720
6,258
Cash Dividends Paid - Total
600
675
901
901
1,051
Issuance/Reduction of Debt, Net
79
117
196
167
67
Net Financing Cash Flow
541
384
574
1,049
968
Net Change in Cash
270
824
1,227
1,533
1,725
Free Cash Flow
7,693
7,089
4,566
1,902
5,267
Other Sources
47
29
151
34
314
Exchange Rate Effect
-
-
-
1
-
Other Uses
229
-
-
401
-

About Sinil Pharmaceutical Co.

View Profile
Address
28 Boksanggol-gil
Chungju-si NC 27304
Korea, Republic Of
Employees -
Website http://www.sinilpharm.com
Updated 09/14/2018
Shinil Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. It operates through following business divisions: Drug, Health Functional Food, Cosmetics, Real Estate, and Other Product. The company was founded by Sung-So Hong in November 1971 and is headquartered in Chungju-si, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.